Advertisement

Innovation

Congressional proposals regarding drug pricing will reduce the financial incentives that spur the discovery and development of new treatments, therefore staunching the flow of biomedical innovation, according to Elizabeth Nabel, MD, president of Brigham Health.

Regardless of the storm of personal and professional drama that seems to follow CEO Elon Musk, there is no denying the vast success of Tesla, which has not only led the auto industry's charge toward electric vehicles but also boasts…

Advertisement

Healthcare may be the most difficult industry in which to launch an innovative new company — even for physicians and others with firsthand, frontline experience in the field — due to increased government regulation and the required scientific backing.

Capital Rx, a pharmacy benefit manager lowering drug prices by building a marketplace that connects pharmacies and employers, was named on Feb. 6 the "Innovation Champion" of Accenture's HealthTech Innovation Challenge.

Advertisement